Enzymes are essential to maintain organisms alive. Some of the reactions they catalyze are associated with a change in reagents chirality, hence their activity can be tracked by using optical means. However, illumination affects enzyme activity: the challenge is to operate at low-intensity regime avoiding loss in sensitivity. Here we apply quantum phase estimation to real-time measurement of invertase enzymatic activity. Control of the probe at the quantum level demonstrates the potential for reducing invasiveness with optimized sensitivity at once. This preliminary effort, bringing together methods of quantum physics and biology, constitutes an important step towards full development of quantum sensors for biological systems.
Enzymes are essential to maintain organisms alive. Some of the reactions they catalyze are associated with a change in reagents chirality, hence their activity can be tracked by using optical means. However, illumination affects enzyme activity: the challenge is to operate at low-intensity regime avoiding loss in sensitivity. Here we apply quantum phase estimation to real-time measurement of invertase enzymatic activity. Control of the probe at the quantum level demonstrates the potential for reducing invasiveness with optimized sensitivity at once. This preliminary effort, bringing together methods of quantum physics and biology, constitutes an important step towards full development of quantum sensors for biological systems.
Abstract Quantum sensing (QS) is a rapidly developing field at the intersection of physics, biology, and nanotechnology. It holds great promise for improving how we detect biomolecules in health, diagnostics, and environmental monitoring, and this potential is reflected in the rapid development and growing interest in advanced biosensing technologies. Traditional sensing methods, while useful, often face limits in sensitivity, speed, and the ability to analyze tiny amounts or subtle changes in biomolecules. QS uses coherence, entanglement, and superposition to achieve much higher sensitivity and precision than classical techniques. These technologies rely on advanced platforms like nitrogen-vacancy centers in diamonds, quantum dots. They can measure tiny changes in magnetic fields, electric charges, or fluorescence signals caused by biomolecules like proteins, DNA, lipids, carbohydrates and metabolites. This review explains the fundamental principles behind QS and explores how various physical platforms are used to detect and study biomolecules. It highlights recent breakthroughs in detecting single molecules, monitoring enzymatic reactions in real time, and imaging biological structures with quantum-level detail. We also discuss how nanotechnology is powering the field, improving integration through nanoparticle coupling, microfluidics, and specialized bio interfaces to target and amplify signals in practical settings. This review discusses current efforts to overcome existing challenges and highlights future directions, including the development of quantum-enhanced clinical sensors, integration with artificial intelligence for data analysis, and hybrid quantum–classical sensing strategies. These advances are expected to accelerate the translation of quantum biosensing technologies from laboratory demonstrations to practical clinical and environmental applications in the coming decade.
Techniques to observe and track single unlabelled biomolecules are crucial for many areas of nanobiotechnology; offering the possibility for lab-on-a-chip medical diagnostics operating at their ultimate detection limits, and to shed light on important nanoscale biological processes such as binding reactions, conformational changes, and motor molecule dynamics. Impressive progress has been made over the past few years to extend the sensitivity of such techniques, primarily via the evanescent field enhancement provided by optical microcavities [1, 2] or plasmonic resonators [3]. However, such approaches expose the biological system to greatly increased optical intensity levels, which can severely impact biological function, growth, structure and viability [4]. Here, we introduce an evanescent biosensing platform that operates at the fundamental precision limit introduced by quantisation of light. This allows a five order-of magnitude reduction in optical intensity whilst maintaining state-of-the-art sensitivity and enabling quantum noise limited tracking of single biomolecules as small as 3.5 nm.
In the emerging field of quantum biology, we begin to see how biological systems exploit quantum mechanics as their efficiency and certain phenomena such as photosynthesis and enzymatic reactions cannot be explained only by classical physics. This paper will shortly review the foundations and axioms of quantum mechanics including wave particle duality, Heisenburg's uncertainty principle and the probabilistic interpretation of a wave function before exploring the first primary topic-quantum tunneling in enzymes. The paper will then provide deeper insights into quantum effects in photosynthesis including coherence, entanglement and the photoelectric effect. Additionally, quantum biology will have profound implications on the future of quantum technology. Leveraging the information scientists have gained about the quantum mechanical functions of biological systems, this paper will delve into the applications of this know-how in quantum technology.
Separating the dynamics of variables that evolve on different timescales is a common assumption in exploring complex systems, and a great deal of progress has been made in understanding chemical systems by treating independently the fast processes of an activated chemical species from the slower processes that proceed activation. Protein motion underlies all biocatalytic reactions, and understanding the nature of this motion is central to understanding how enzymes catalyze reactions with such specificity and such rate enhancement. This understanding is challenged by evidence of breakdowns in the separability of timescales of dynamics in the active site form motions of the solvating protein. Quantum simulation methods that bridge these timescales by simultaneously evolving quantum and classical degrees of freedom provide an important method on which to explore this breakdown. In the following dissertation, three problems of enzyme catalysis are explored through quantum simulation.
Quantum sensors emerged among quantum technologies as the ones with promising potential applications in the near future. This perspective reviews two leading quantum sensing platforms and their advancements toward biological applications: quantum light sources and color centers in diamonds. Quantum light, including squeezed states and N00N states, allows enhanced phase measurements by surpassing the classical shot noise limits. This advantage can be exploited in several contexts, enabling improved resolution and sensitivity, which are particularly valuable in biological contexts where traditional high-intensity illumination could damage or alter delicate samples. In parallel, color centers in diamonds, specifically nitrogen-vacancy and silicon-vacancy centers, also emerged as promising for sensing applications due to their high sensitivity and biocompatibility. These sensors enable detailed intracellular measurements, such as temperature detection, and show potential for measuring magnetic fields of biological origin. Despite these advancements, significant challenges remain in translating these technologies from a controlled laboratory environment to practical, widely applicable devices for diverse biological applications. Overcoming these challenges is crucial for unlocking the full potential of quantum sensors in the biological field.
Chiral discrimination of enantiomeric biomolecules is vital in chemistry, biology, and medicine. Conventional methods, relying on circularly polarized light, face weak chiroptical signals and potential photodamage. Despite extensive efforts to improve sensitivity under low-photon exposure, classical chiral probes remain fundamentally bounded by the shot-noise limit due to quantum fluctuations. To beat these limitations, we demonstrate quantum-elevated chiral discrimination using continuous-variable polarization-entangled states as moderate-photon-flux, high-sensitivity, quantum-noise-squeezed chiral probes. We achieve a 5 dB improvement beyond the SNL in distinguishing L- and D-amino acids in liquid phase. This non-destructive, biocompatible protocol enables high-sensitivity chiral analysis, with broad implications for drug development, biochemical research, environmental monitoring, and asymmetric synthesis.